Articles

Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous b1/b2 globin gene deletion) mice

Laboratory of Biochemistry and Vascular Biology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
Laboratory of Cellular Hematology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
Laboratory of Cellular Hematology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA;Division of Internal Medicine, University of Zurich, Switzerland
Functional Genomics Center Zurich, Swiss Federal Institute of Technology Zurich / University of Zurich, Switzerland;Division of Internal Medicine, University of Zurich, Switzerland
Division of Internal Medicine, University of Zurich, Switzerland
Division of Internal Medicine, University of Zurich, Switzerland
Laboratory of Biochemistry and Vascular Biology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
Division of Internal Medicine, University of Zurich, Switzerland;Center of Evolutionary Medicine, University of Zurich, Switzerland
Laboratory of Cellular Hematology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.117325